Literature DB >> 12098760

Cloning, expression of the abrin-a A-chain in Escherichia coli and measurement of the biological activities in vitro.

Liu-Ting Qing1, Xiao-Ling Qu.   

Abstract

The coding sequence of abrin-a A-chain (ABRaA) gene was obtained by RT-PCR and cloned into the expression vector pET28b. The mature ABRaA has been highly expressed in the cytoplasm of Escherichia coli by 1 mmol/L IPTG induction, and the yield of the soluble recombinant protein was 4 mg/L of induced culture. The recombinant ABRaA was purified to be homogeneity. The biological activities of expressed ABRaA were demonstrated in vitro. It strongly inhibited the protein biosynthesis of rabbit reticulocyte lysates, with an IC(50) of 0.08 nmol/L. It also depurinated 28 S rRNA through cleaving at the A4324 site in rat liver ribosomes by its N-glycosidase activity. These data suggested that the recombinant ABRaA could be used for the preparation of immunotoxins as a potential cancer chemotherapeutic agent.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12098760

Source DB:  PubMed          Journal:  Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)        ISSN: 0582-9879


  3 in total

1.  A Monoclonal-Monoclonal Antibody Based Capture ELISA for Abrin.

Authors:  Christina C Tam; Luisa W Cheng; Xiaohua He; Paul Merrill; David Hodge; Larry H Stanker
Journal:  Toxins (Basel)       Date:  2017-10-18       Impact factor: 4.546

2.  Production and Evaluation of an Avian IgY Immunotoxin against CD133+ for Treatment of Carcinogenic Stem Cells in Malignant Glioma: IgY Immunotoxin for the Treatment of Glioblastoma.

Authors:  Elda-Georgina Chavez-Cortez; Gustavo Vargas Felix; Edgar Rangel López; Julio Sotelo; Carlos Martínez-Canseco; Verónica Pérez-de la Cruz; Benjamin Pineda
Journal:  J Oncol       Date:  2019-06-02       Impact factor: 4.375

3.  Abrin Toxicity and Bioavailability after Temperature and pH Treatment.

Authors:  Christina C Tam; Thomas D Henderson; Larry H Stanker; Xiaohua He; Luisa W Cheng
Journal:  Toxins (Basel)       Date:  2017-10-13       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.